Tuberculosis and Air Travel Ibrahim Abubakar, MBBS, PhD, FFPH Consultant Epidemiologist Section Head - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

Tuberculosis and Air Travel Ibrahim Abubakar, MBBS, PhD, FFPH Consultant Epidemiologist Section Head

Description:

Tuberculosis and Air Travel. Ibrahim Abubakar, MBBS, PhD, FFPH ... McFarland JW et al. Exposure to Mycobacterium tuberculosis during air travel. ... – PowerPoint PPT presentation

Number of Views:132
Avg rating:3.0/5.0
Slides: 24
Provided by: sim4150
Category:

less

Transcript and Presenter's Notes

Title: Tuberculosis and Air Travel Ibrahim Abubakar, MBBS, PhD, FFPH Consultant Epidemiologist Section Head


1
Tuberculosis and Air TravelIbrahim
Abubakar, MBBS, PhD, FFPHConsultant
Epidemiologist / Section HeadTuberculosis
SectionRespiratory and Systemic Infections
DepartmentCentre for InfectionsColindale, London
2
Talk outline
  • Rationale
  • Evidence base
  • WHO Guidelines
  • NICE
  • HPA Interpretation

3
Rationale
Newsworthy - More political than public
health International cross border
4
Evidence
  • No cases of TB disease reported among those known
    to have been infected with M. tuberculosis during
    air travel
  • All instances of transmission involved highly
    infectious (smear positive) cases
  • 2 of whom had MDR disease
  • Overall notification rate of 0.05 per 100 000
    long haul passengers (BA)

5
Evidence
6
UK incidents
Four All had negative Mantoux
7
WHO Guidelines
2006
2008
1998
8
Infectious or potentially infectious
  • Infectious TB. All cases of respiratory
    (pulmonary or laryngeal) TB which are sputum
    smear-positive and culture-positive (if culture
    is available).
  • Potentially infectious TB. All cases of
    respiratory (pulmonary or laryngeal) TB which are
    sputum smear-negative and culture-positive
    (susceptible, MDR-TB or XDR-TB).
  • Non-infectious TB. All cases of respiratory TB
    which have two consecutive negative sputum-smear
    and negative culture (if culture is available)
    results.

9
WHO guidelines
  • For travellers, Public Health Authorities,
    Physicians and Airlines
  • Pre and post travel
  • For Travellers
  • People with infectious or potentially
    infectious TB should postpone all travel by
    commercial air transportation of any flight
    duration until they become non infectious.

10
Physicians Pre and Post travel
  • Pre-travel
  • Inform all infectious and potentially
    infectious TB patients that they must not travel
    by air on any commercial flight of any duration
    until non infectious
  • - 2 weeks of adequate treatment and they are
    sputum smear negative on at least two occasions
  • - 2 consecutive negative sputum-culture results
    if MDR or XDR.
  • Promptly inform the relevant public health
    authority when if such a TB patient intends to
    travel against medical advice.
  • Inform the public health authority of
    exceptional circumstances
  • Post-travel
  • Inform the public health authority when an
    infectious or potentially infectious TB patient
    has a history of commercial air travel within the
    previous 3 months.

WHO guidelines
11
Public Health Authorities Pre travel
  • Inform the concerned airline of infectious and
    potentially infectious passengers travelling
    against medical advice and request that boarding
    be denied.
  • If patient has exceptional circumstances,
    ensure that the airline(s) and all involved
    authorities have agreed the procedures for travel.

WHO guidelines
12
Public Health Authorities Post Travel
  • Undertake risk assessment
  • Inform all countries involved (departure and
    landing).
  • Coordination between countries necessary.
  • Share passenger information.
  • Inform the National IHR Focal Point.
  • Collaborate on research concerning TB and air
    travel.

WHO guidelines
13
Assessing whether contact tracing is needed
WHO guidelines
14
Aircraft air flow
i.e. those passengers seated in the same row and
in the two rows in front of and behind the index
case
WHO guidelines
15
Airline companies
  • Pre-travel
  • Deny boarding to infectious or potentially
    infectious TB when requested.
  • Ensure ventilation is on after 30 minutes
    ground delay.
  • Requirements and standards for filtration
    systems.
  • Training for cabin crews.
  • Adequate emergency supplies on board
  • Post-travel
  • Airline companies should provide all available
    contact information, in accordance with
    applicable legal requirements including the IHR.

WHO guidelines
16
NICE
17
.
  • Public health authorities may refine criteria on
    infectiousness according to national guidelines
  • Public health authorities may follow national
    policies and guidelines regarding TB contact
    investigation involving potentially exposed
    travellers in their jurisdiction, in accordance
    with requirements under the IHR

18
HPA Interpretation Pre travel
  • Discourage all passengers with infectious or
    potential infectious TB from travel and inform
    local HPU
  • Where there are exceptional personal circumstance
    discuss with HPU

19
HPA Interpretation Post travel
Clinician informs HPU
Then HPU sends inform and advise letters to
passengers in the UK
Undertake a risk assessment Index case smear
positive Flight gt8 hrs in last 3/12
International contacts dealt with through TB
Section, CfI in liaison with HPU
HPU liaises with CfI to agree which authority
undertaking the investigation
Crew inform HPU, and therefore, airline
assess as occupational / office type exposure
HPU obtains passenger details for those sitting
in same, and two adjacent rows
20
HPA Interpretation During Flight
  • Passengers and crew should be reassured
  • Airline should be encouraged to keep contact
    details to support subsequent public health
    action

21
HPA Interpretation
  • Draft agreed
  • To be published by the National Knowledge Service
    for TB after further review

22
  • Thank you
  • and now I am off to take my 8 hour train
    to London

23
References
Driver CR et al. Transmission of M. tuberculosis
associated with air travel. Journal of the
American Medical Association, 1994,
27210311035. McFarland JW et al. Exposure to
Mycobacterium tuberculosis during air travel.
Lancet, 1993, 342112113. Exposure of passengers
and flight crew to Mycobacterium tuberculosis on
commercial aircraft, 19921995. Morbidity and
Mortality Weekly Report, 1995, 44137140. Miller
MA, Valway SE, Onorato IM. Tuberculosis risk
after exposure on airplanes. Tubercle and Lung
Disease, 1996, 77414419. Kenyon TA et al.
Transmission of multidrug-resistant Mycobacterium
tuberculosis during a long airplane flight. New
England Journal of Medicine, 1996,
334933938. Moore M, Fleming KS, Sands L. A
passenger with pulmonary/laryngeal tuberculosis
no evidence of transmission on two short flights.
Aviation, Space, and Environmental Medicine,
1996, 6710971100. Vassiloyanakopoulos A et al.
A case of tuberculosis on a long-distance flight
the difficulties of the investigation.
Eurosurveillance, 1999, 4(9)96-97. Chemardin J
et al. Contact-tracing of passengers exposed to
an extensively drug-resistant tuberculosis case
during an air flight from Beirut to Paris,
October 2006. Eurosurveillance, 2007, 12(12)6
December. Wang PD. Two-step tuberculin testing of
passengers and crew on a commercial airplane.
American Journal of Infection Control, 2000,
28(3)233238. Parmet AJ. Tuberculosis on the
flight deck. Aviation, Space, and Environmental
Medicine, 1999, 70(8)817818. Whitlock G, Calder
L, Perry H. A case of infectious tuberculosis 16.
on two longhaul aircraft flights contact
investigation. New Zealand Medical Journal, 2001,
114(1137)353355 Tuberculosis exposure feared on
India-to-U.S. flight. Clinical Infectious
Diseases News, 2008, 461 March.
Write a Comment
User Comments (0)
About PowerShow.com